VAPOTHERM INC (VAPO)

US9221073052 - Common Stock

1.27  +0.08 (+6.72%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

VAPOTHERM INC

NYSE:VAPO (12/14/2023, 7:19:45 PM)

1.27

+0.08 (+6.72%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap7.80M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

VAPO Daily chart

Company Profile

Vapotherm Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Exeter, New Hampshire and currently employs 261 full-time employees. The company went IPO on 2018-11-14. Vapotherm, Inc. is a medical technology company. The company is focused on the care of patients of all ages suffering from the respiratory distress associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company has five versions of its Precision Flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its High Velocity Therapy systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow Hi-VNI system offers connectivity to a hospital’s nurse call system to alert the staff to disruption of the patient’s respiratory support.

Company Info

VAPOTHERM INC

100 Domain Drive

Exeter NEW HAMPSHIRE 03833

P: 16036580411

CEO: Joseph Army

Employees: 261

Website: https://vapotherm.com/

VAPO News

News Image9 days ago - OnymosOnymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)

/PRNewswire/ -- Onymos, developer of the world's first Features-as-a-Service platform, and Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm"), a global medical...

News Image14 days ago - Vapotherm, Inc.Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

/PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the...

News Image23 days ago - Vapotherm, Inc.Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute

/PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced that David Yamane, MD was awarded the Star Research Award by the...

News Imagea month ago - Vapotherm, Inc.Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market

/PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology company specializing in the development and...

News Imagea month ago - Market News VideoTop Buys by Top Brass: CEO Army's $348K Bet on VAPO
News Imagea month ago - Vapotherm, Inc.Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results

/PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced fourth quarter and fiscal year 2023 financial results and...

VAPO Twits

Here you can normally see the latest stock twits on VAPO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example